<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04698434</url>
  </required_header>
  <id_info>
    <org_study_id>Y015</org_study_id>
    <nct_id>NCT04698434</nct_id>
  </id_info>
  <brief_title>The Best Dose of Esketamine for Day Surgery of Pediatric Circumcision Pediatric Circumcision</brief_title>
  <official_title>The Best Dose of Esketamine for Day Surgery of Pediatric Circumcision</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yangzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yangzhou University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In recent years, daytime operation has been developed gradually in China. Circumcision in&#xD;
      children is a common type of daytime operation. The nature of the operation and the object of&#xD;
      the operation determine that the anesthetic drugs used should induce fast, wake up quickly&#xD;
      and recover in a high quality.&#xD;
&#xD;
      Esketamine is an S-enantiomer of ketamine, which is newly marketed in China. Compared with&#xD;
      ketamine, it has stronger effect on NMDA receptor, and its sedative effect is about twice as&#xD;
      high. The occurrence frequency of respiratory depression and hypotension is lower than that&#xD;
      of other anesthetics and analgesics, which can provide good analgesic and sedative effect for&#xD;
      surgical anesthesia.&#xD;
&#xD;
      In clinical practice, ketamine combined with sevoflurane has been widely used in children's&#xD;
      microsurgery, but there has been no report on Esketamine combined with sevoflurane&#xD;
      anesthesia.&#xD;
&#xD;
      In order to find out the best combined dose, this paper compares the single administration of&#xD;
      three different doses of esketamine combined with sevoflurane anesthesia in the circumcision&#xD;
      of children.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate the optimal dose of esketamine combined with sevoflurane for pediatric&#xD;
      circumcision. Methods children who underwent day surgery of pediatric circumcision were&#xD;
      randomly divided into 3 groups according to the random number table method:0.5mg/kg&#xD;
      esketamine group (Group A), 0.75mg/kg esketamine group (Group B) and 1.0mg/kg of esketamine&#xD;
      group (Group C), with 30 people in each group. mask inhalation of sevoflurane anesthesia,&#xD;
      each group was given a single intravenous dose of the corresponding esketamine. Heart rate&#xD;
      (HR), mean arterial pressure (MAP), pulse oxygen saturation (SpO2) and respiratory rate (RR)&#xD;
      were recorded at room entry (T0), intravenous ketamine administration (T1), operation&#xD;
      initiation (T2), intraoperative central ligation (T3) and operation completion (T4).The&#xD;
      number and total amount of ketamine added intraoperatively were recorded. Duration of&#xD;
      operation, time to open eyes and time to answer were recorded. The Eastern Ontario Children's&#xD;
      Hospital pain Score (CHEOPS score) and the modified Bieri pain score were recorded when&#xD;
      awake, 2 hours and 6 hours postoperatie. MOAA/S score was recorded at 15, 30 and 60min after&#xD;
      surgery. Intraoperative and post-operative adverse reactions were recorded, including&#xD;
      hypersensitivity, agitation, nausea and vomiting, dizziness, diplopia, etc.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2021</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>children who underwent day surgery of pediatric circumcision were randomly divided into 3 groups according to the random number table method:0.5mg/kg esketamine group (Group A), 0.75mg/kg esketamine group (Group B) and 1.0mg/kg of esketamine group (Group C), with 30 people in each group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>recovery time</measure>
    <time_frame>up to 2 hour</time_frame>
    <description>the time from stopping sevoflurane to resuscitation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CHEOPS score</measure>
    <time_frame>up to 6 hours</time_frame>
    <description>The Eastern Ontario Children's Hospital Pain Score (CHEOPS score) at the time of 2h and 6h after surgery</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Phimosis</condition>
  <arm_group>
    <arm_group_label>0.5mg/kg esketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.5mg/kg esketamine group will be given a single intravenous 0.5mg/kg esketamine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>.75mg/kg esketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>0.75mg/kg esketamine groupwill be given a single intravenous 0.75mg/kg esketamine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1.0mg/kg esketamine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1.0mg/kg esketamine group will be given a single intravenous 1.5mg/kg esketamine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esketamine</intervention_name>
    <description>each group was given a single intravenous dose of the corresponding esketamine.</description>
    <arm_group_label>.75mg/kg esketamine group</arm_group_label>
    <arm_group_label>0.5mg/kg esketamine group</arm_group_label>
    <arm_group_label>1.0mg/kg esketamine group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  phimosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cardiopathy&#xD;
&#xD;
          -  asthma&#xD;
&#xD;
          -  dysgnosia&#xD;
&#xD;
          -  surdimutism&#xD;
&#xD;
          -  hepatopathy or nephropathy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sun Ji Hong, bachelor</last_name>
    <role>Study Chair</role>
    <affiliation>Yangzhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MA HONG, bachelor</last_name>
    <phone>13675161040</phone>
    <email>mahongyzdaxue@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LIU Me YU, MASTER</last_name>
    <phone>17761980727</phone>
    <email>myliu@yzu.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Affiliated hospital of yangzhou university</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225100</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ma Hong</last_name>
      <phone>13675161040</phone>
      <email>mahongyzdaxue@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 31, 2020</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yangzhou University</investigator_affiliation>
    <investigator_full_name>Ma Hong</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Esketamine</keyword>
  <keyword>Sevoflurane</keyword>
  <keyword>Children</keyword>
  <keyword>circumcise</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phimosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esketamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

